Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Clinical Study to Map the HLA GENomic Region and Its potEntial aSsocIation With Selected diSeases in the Greek Population

NCT06227468 is registered in ClinicalTrials.gov with Athens LifeTech Park as lead sponsor.

NCT NCT06227468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06227468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Clinical Study to Map the HLA GENomic Region and Its potEntial aSsocIation With Selected diSeases in the Greek Population
Lead sponsor
Athens LifeTech Park
Phase
Observational
Overall status
Recruiting
Start date
December 12, 2023
Completion date
August 31, 2026
Enrollment
12,000 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, chronic renal failure, gastrointestinal diseases, haematologic disease, healthy, metabolic disease, neurologic disorder, psychiatric disorder, respiratory disease, rheumatologic disease